Share Prices & Company Research

Stockbroking

Smith & Nephew

Current Price 1363.00p Bid 1310.00p Ask 1650.00p Change 1.38%
Last Updated: 06/04/2020 06:48. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.

Financial Highlights Year Ended 31/12/2019

Revenue
$5,138.00m
Operating Profit/Loss
$815.00m
Dividend yield (%)
1.70
Total dividend for year
$0.3750
Dividend cover
2.73
P/E Ratio
22.00
More Financials

Key Personnel

Roberto Quarta
Chairman
Roland Diggelmann
Chief Executive Officer

Stock Details

EPIC
SN.
ISIN
GB0009223206
Shares in Issue
874.70m
Market cap
£11,922.22m
Sector
Health Care

Analyst Views (1)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1,363.00p
Bid Price
1,310.00p
Ask Price
1,650.00p
Volume
1,601,541
Change Today
18.50p
% Change Today
1.38%
Open
1,343.00p
Previous Close
1,363.00p
Intraday High
1,379.50p
Intraday Low
1,338.50p
52 Week High
1,990.00p
52 Week Low
1,152.50p
52 week high and low figures quoted above are calculated from intraday price data.

Smith & Nephew News

Tuesday broker round-up 31 Mar 2020 | 13:42 Smith & Nephew withdraws guidance after Covid-19 spreads 30 Mar 2020 | 07:28 Smith & Nephew CFO Baker to step down in April 05 Mar 2020 | 10:36 Tuesday broker round-up 25 Feb 2020 | 14:07 Smith & Nephew FY profits slip despite improved revenues 20 Feb 2020 | 08:41 Wednesday broker round-up 15 Jan 2020 | 13:03 Wednesday broker round-up 13 Nov 2019 | 12:38 Monday broker round-up 21 Oct 2019 | 13:32 Berenberg reiterates 'buy' rating on Smith and Nephew 07 Oct 2019 | 13:36 Smith & Nephew raises revenue growth guidance after solid first half 31 Jul 2019 | 09:15 Tuesday broker round-up 23 Jul 2019 | 17:15 Wednesday broker round-up 26 Jun 2019 | 12:10 Smith & Nephew to buy Swiss firm Atracsys 11 Jun 2019 | 07:28 Smith & Nephew\'s acquisition of Brainlab completed 03 Jun 2019 | 08:20 Smith & Nephew shares rise as board updates revenue guidance 02 May 2019 | 09:28 Monday broker round-up 29 Apr 2019 | 13:50 Smith & Nephew to acquire pressure injury monitor maker Leaf 01 Apr 2019 | 09:50 Smith & Nephew to buy US biotech Osiris Therapeutics for $19 a share 12 Mar 2019 | 13:20 Smith & Nephew drops on NuVasive deal report 11 Feb 2019 | 12:40 Smith & Nephew eyes more M&A after strong finish to year 07 Feb 2019 | 08:37 Thursday preview: BoE in focus 06 Feb 2019 | 16:33 Thursday broker round-up 31 Jan 2019 | 15:15 Broker tips: Intu Properties, Smith&Nephew 02 Jan 2019 | 16:45 JPMorgan cuts Smith & Nephew after outperformance 02 Jan 2019 | 10:27 Smith and Nephew acquires US orthopaedics outfit 18 Dec 2018 | 17:49

Income Statement

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Continuing Operations
Revenue
5,138.00
4,904.00
Operating Profit/Loss
815.00
863.00
Net Interest
-55.00
-51.00
Pre-Tax Profit
743.00
871.00
Profit After Tax from continuing operations
600.00
663.00
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
600.00
663.00
Attributable to:
Equity Holders of Parent Company
600.00
663.00
Minority Interests
n/a
n/a
Total Dividend Paid
$0.3750
$0.3600
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2019
31 Dec 2018
Basic
68.60c
76.00c
Diluted
68.40c
75.70c
Adjusted
102.20c
100.90c
Dividend per Share
$0.3750
$0.3600

Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
1,323.00
1,062.00
Intangible Assets
4,356.00
3,547.00
Investment Properties
n/a
n/a
Investments
110.00
139.00
Other Financial Assets
n/a
n/a
Other Non-Current Assets
291.00
234.00
Current Assets
Inventories
1,614.00
1,395.00
Trade & Other Receivables
1,328.00
1,317.00
Cash at Bank & In Hand
277.00
365.00
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
9,299.00
8,059.00

Liabilities

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Current Liabilities
Borrowings
72.00
164.00
Other Current Liabilities
1,492.00
1,301.00
Total Current Liabilities
1,564.00
1,465.00
Non-Current Liabilities
Borrowings
1,975.00
1,301.00
Provisions
381.00
252.00
Other Non-Current Liabilities
238.00
167.00
Total Non-Current Liabilities
2,594.00
1,720.00
Other Liabilities
n/a
n/a
Total Liabilities
4,158.00
3,185.00

Net Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Net Assets
5,141.00
4,874.00

Capital & Reserves

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Share Capital
177.00
177.00
Share Premium Account
610.00
608.00
Other Reserves
-495.00
-536.00
Retained Earnings
4,849.00
4,625.00
Shareholders Funds
5,141.00
4,874.00
Minority Interests/Other Equity
n/a
n/a
Total Equity
5,141.00
4,874.00

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Final
02 Apr 2020
06 May 2020
23.10¢
Interim
03 Oct 2019
30 Oct 2019
14.40¢
Final
04 Apr 2019
08 May 2019
22.00¢
Interim
04 Oct 2018
31 Oct 2018
14.00¢
Final
05 Apr 2018
09 May 2018
22.70¢
Interim
05 Oct 2017
01 Nov 2017
12.30¢
Final
30 Mar 2017
10 May 2017
18.50¢
Interim
06 Oct 2016
25 Oct 2016
12.30¢
Final
21 Apr 2016
11 May 2016
19.00¢
Interim
08 Oct 2015
27 Oct 2015
11.80¢

Dividend Metrics

Year End Date
31 Dec 2019
31 Dec 2018
Dividend growth
4.17%
2.86%
Dividend yield
1.70%
2.00%
Dividend cover
2.73
2.80
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 26th March 2020
Hide
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.
Hide